What we do
COMMITMENT TO QUALITY
Quality and compliance are not afterthoughts—they are the foundation of everything we do.
Quality Management System
GMP-aligned processes and documentation
Data Integrity
ALCOA+ principles applied throughout
Regulatory Compliance
Continuous monitoring and adaptation
Continuous Improvement
Learning and evolving with the industry
- What we do
In-Licensing, Marketing Authorisation & UK/EU Commercialisation
At Healion Pharma, we expand our portfolio through strategic in-licensing, MA acquisition, distribution partnerships, and export opportunities—supporting product owners with compliant, end-to-end regulatory and lifecycle ownership across the UK & EU.
We work with CDMOs, CMOs, manufacturers and commercial organisations seeking a dependable, compliance-driven partner to unlock product value—turning regulatory approval into sustainable market success.
In-Licensing, Distribution & Strategic Growth
We identify and secure value products through in-licensing, MA transfers, distribution agreements, and export pathways—supported by disciplined compliance and commercial planning
- Partnering with product owners, manufacturers, CDMOs & CMOs
- Unlocking UK/EU market potential with compliance-first execution
Marketing Authorisation Applications
End-to-end preparation and submission of UK & EU Marketing Authorisations, built with regulatory foresight to withstand assessment and support long-term success.
- National, DCP and MRP procedures
- Generic, hybrid & established product applications
- Pathway selection + full ownership to approval
Regulatory Strategy & Dossier Development
Submission strategies that withstand regulatory challenge, supported by evidence-based dossier building aligned with current UK and EU expectations.
- High-quality CTD compilation
- Gap analysis & remediation
- Scientific justification & positioning
Lifecycle & Compliance Management
Marketing Authorisation is the start. We protect long-term compliance, label integrity, and MA value through proactive post-approval governance.
- Variations, renewals & change management
- SmPC / PIL / labelling maintenance
- Regulatory intelligence monitoring
Product Selection & Portfolio Development
We prioritise medicines with clear pathways, strong market rationale, and reliable supply—building durable, compliant portfolios that support long-term growth.
- Regulatory feasibility & pathway clarity
- Supply chain reliability
- Market access considerations
- Lifecycle potential & sustainability
If you are a CDMO, CMO, distributor, or product owner seeking support for in-licensing, MA transfer, distribution, or export—let’s explore a compliant route to UK/EU success.
- WHAT WE DO
In-Licensing, Marketing Authorisation & UK/EU Commercialisation
At Neuragenix Pharma, we expand our portfolio through strategic in-licensing, MA acquisition, distribution partnerships, and export opportunities—supporting product owners with compliant, end-to-end regulatory and lifecycle ownership across the UK & EU.
We work with CDMOs, CMOs, manufacturers and commercial organisations seeking a dependable, compliance-driven partner to unlock product value—turning regulatory approval into sustainable market success.
In-Licensing, Distribution & Strategic Growth
We identify and secure value products through in-licensing, MA transfers, distribution agreements, and export pathways—supported by disciplined compliance and commercial planning
- Partnering with product owners, manufacturers, CDMOs & CMOs
- Unlocking UK/EU market potential with compliance-first execution
Marketing Authorisation Applications
End-to-end preparation and submission of UK & EU Marketing Authorisations, built with regulatory foresight to withstand assessment and support long-term success.
- National, DCP and MRP procedures
- Generic, hybrid & established product applications
- Pathway selection + full ownership to approval
Regulatory Strategy & Dossier Development
Submission strategies that withstand regulatory challenge, supported by evidence-based dossier building aligned with current UK and EU expectations.
- High-quality CTD compilation
- Gap analysis & remediation
- Scientific justification & positioning
Lifecycle & Compliance Management
Marketing Authorisation is the start. We protect long-term compliance, label integrity, and MA value through proactive post-approval governance.
- Variations, renewals & change management
- SmPC / PIL / labelling maintenance
- Regulatory intelligence monitoring
Product Selection & Portfolio Development
We prioritise medicines with clear pathways, strong market rationale, and reliable supply—building durable, compliant portfolios that support long-term growth.
- Regulatory feasibility & pathway clarity
- Supply chain reliability
- Market access considerations
- Lifecycle potential & sustainability
Let's build value together
We partner with CDMOs, CMOs, distributors, product owners, and licensors to bring essential medicines to market through compliant, efficient regulatory pathways.
- What we do
In-Licensing, Marketing Authorisation & UK/EU Commercialisation
At Healion Pharma, we expand our portfolio through strategic in-licensing, MA acquisition, distribution partnerships, and export opportunities—supporting product owners with compliant, end-to-end regulatory and lifecycle ownership across the UK & EU.
We work with CDMOs, CMOs, manufacturers and commercial organisations seeking a dependable, compliance-driven partner to unlock product value—turning regulatory approval into sustainable market success.
In-Licensing, Distribution & Strategic Growth
We identify and secure value products through in-licensing, MA transfers, distribution agreements, and export pathways—supported by disciplined compliance and commercial planning
- Partnering with product owners, manufacturers, CDMOs & CMOs
- Unlocking UK/EU market potential with compliance-first execution
Marketing Authorisation Applications
End-to-end preparation and submission of UK & EU Marketing Authorisations, built with regulatory foresight to withstand assessment and support long-term success.
- National, DCP and MRP procedures
- Generic, hybrid & established product applications
- Pathway selection + full ownership to approval
Regulatory Strategy & Dossier Development
Submission strategies that withstand regulatory challenge, supported by evidence-based dossier building aligned with current UK and EU expectations.
- High-quality CTD compilation
- Gap analysis & remediation
- Scientific justification & positioning
Lifecycle & Compliance Management
Marketing Authorisation is the start. We protect long-term compliance, label integrity, and MA value through proactive post-approval governance.
- Variations, renewals & change management
- SmPC / PIL / labelling maintenance
- Regulatory intelligence monitoring
Product Selection & Portfolio Development
We prioritise medicines with clear pathways, strong market rationale, and reliable supply—building durable, compliant portfolios that support long-term growth.
- Regulatory feasibility & pathway clarity
- Supply chain reliability
- Market access considerations
- Lifecycle potential & sustainability
If you are a CDMO, CMO, distributor, or product owner seeking support for in-licensing, MA transfer, distribution, or export—let’s explore a compliant route to UK/EU success.
In-Licensing, Marketing Authorisation & UK/EU Commercialisation
At Healion Pharma, we expand our portfolio through strategic in-licensing, MA acquisition, distribution partnerships, and export opportunities—supporting product owners with compliant, end-to-end regulatory and lifecycle ownership across the UK & EU.
We work with CDMOs, CMOs, manufacturers and commercial organisations seeking a dependable, compliance-driven partner to unlock product value—turning regulatory approval into sustainable market success.
In-Licensing, Distribution & Strategic Growth
We identify and secure value products through in-licensing, MA transfers, distribution agreements, and export pathways—supported by disciplined compliance and commercial planning.
- Partnering with product owners, manufacturers, CDMOs & CMOs
- Unlocking UK/EU market potential with compliance-first execution
Marketing Authorisation Applications
End-to-end preparation and submission of UK & EU Marketing Authorisations, built with regulatory foresight to withstand assessment and support long-term success.
- National, DCP and MRP procedures
- Generic, hybrid & established product applications
- Pathway selection + full ownership to approval
Regulatory Strategy & Dossier Development
Submission strategies that withstand regulatory challenge, supported by evidence-based dossier building aligned with current UK and EU expectations.
- High-quality CTD compilation
- Gap analysis & remediation
- Scientific justification & positioning
Lifecycle & Compliance Management
Marketing Authorisation is the start. We protect long-term compliance, label integrity, and MA value through proactive post-approval governance.
- Variations, renewals & change management
- SmPC / PIL / labelling maintenance
- Regulatory intelligence monitoring
Product Selection & Portfolio Development
We prioritise medicines with clear pathways, strong market rationale, and reliable supply—building durable, compliant portfolios that support long-term growth.
- Regulatory feasibility & pathway clarity
- Market access considerations
- Supply chain reliability
- Lifecycle potential & sustainability
If you are a CDMO, CMO, distributor, or product owner seeking support for in-licensing, MA transfer, distribution, or export—let’s explore a compliant route to UK/EU success.
Talk to UsFULL-SPECTRUM REGULATORY EXECUTION
We provide end-to-end regulatory services as a Marketing Authorisation holder, not as consultants. Every service is delivered with ownership, accountability, and compliance excellence.
Marketing Authorisation Applications
Strategic submission planning and execution across UK and EU regulatory pathways for generic, hybrid, and established products.
- National Procedure applications (UK MHRA)
- Decentralised Procedure (DCP) coordination across multiple EU member states
- Mutual Recognition Procedure (MRP) for existing national authorisations
- Generic applications with comprehensive bioequivalence assessments
- Hybrid applications leveraging published literature and bridging studies
- Well-established use applications for established medicinal products
- Regulatory pathway selection and optimization based on product characteristics
- Complete CTD dossier compilation aligned with ICH M4 guidelines
Lifecycle & Compliance Management
Proactive management of post-approval obligations, variations, and regulatory maintenance throughout the product lifecycle.
Â
- Type IA, IB, and II variation applications for quality, safety, and efficacy changes
- Marketing Authorisation renewals ensuring continued compliance and market presence
- SmPC (Summary of Product Characteristics) updates reflecting current scientific knowledge
- Labelling and packaging artwork review and regulatory approval coordination
- Annual reassessment and periodic safety update report (PSUR) management
- Post-approval commitments tracking and fulfillment
- Regulatory intelligence monitoring for new guidance impacting existing MAs
- Authority correspondence management and query response coordination
Regulatory Strategy & Dossier Development
Scientifically robust, strategically aligned dossiers built on comprehensive gap analysis and regulatory intelligence.
- Gap analysis identifying documentation deficiencies and strategic solutions
- Module 2 (CTD summaries) development with critical evaluation and justification
- Module 3 (Quality) compilation including pharmaceutical development and manufacturing
- Literature-based Module 4 and 5 strategies for non-clinical and clinical sections
- Scientific justification for regulatory positions and alternative approaches
- Reference product selection and comparability assessments
- Regulatory intelligence monitoring for guidance updates and precedent analysis
- Authority pre-submission consultation strategy and engagement planning
In-Licensing & Portfolio Growth
Strategic MA acquisition, regulatory transfer management, and portfolio integration for long-term value creation.
- Marketing Authorisation transfer applications and regulatory coordination
- Due diligence on existing MAs including compliance history and post-approval commitments
- Regulatory gap assessment for acquired products and remediation planning
- Portfolio integration and lifecycle planning post-acquisition
- In-licensing negotiation support with regulatory and compliance perspectives
- Distribution partnership agreements with MA holder oversight
- Export certificate applications enabling market access beyond UK and EU
- Product lifecycle optimization identifying opportunities for line extensions and improvements
Â
Â
Partnership & Distribution Enablement
Collaborative engagement with manufacturers, distributors, and commercial partners to ensure compliant market access.
- CDMO and CMO coordination for manufacturing and quality agreement alignment
- Distributor partnership structuring with clear MA holder oversight
- Qualified Person (QP) coordination and batch release protocols
- Pharmacovigilance agreement setup and safety data exchange procedures
- Import/export authorization support and regulatory certification
- Supply chain continuity planning and regulatory risk mitigation
- Commercial partner training on MA requirements and compliance obligations
- Multi-party coordination ensuring alignment across regulatory, quality, and commercial functions